These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
566 related items for PubMed ID: 7485343
1. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study. Kellner LH, Weiner Z, Weiss RR, Neuer M, Martin GM, Mueenuddin M, Bombard A. Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343 [Abstract] [Full Text] [Related]
2. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome. Bahado-Singh R, Oz U, Rinne K, Hunter D, Cole L, Mahoney MJ, Baumgarten A. Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756 [Abstract] [Full Text] [Related]
3. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol. Extermann P, Bischof P, Marguerat P, Mermillod B. Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261 [Abstract] [Full Text] [Related]
5. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome. Wenstrom KD, Owen J, Chu DC, Boots L. Am J Obstet Gynecol; 1997 Nov; 177(5):987-91. PubMed ID: 9396880 [Abstract] [Full Text] [Related]
7. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies. Bahado-Singh RO, Oz U, Shahabi S, Mahoney MJ, Baumgarten A, Cole LA. Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551 [Abstract] [Full Text] [Related]
12. Prospective prenatal serum screening for Down syndrome in Venezuela. Alvarez-Nava F, Soto M, Morales-Machín A, Rojas A, Urdaneta K, Cañizález J. Int J Gynaecol Obstet; 2008 Dec; 103(3):241-5. PubMed ID: 18817910 [Abstract] [Full Text] [Related]
15. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population. Chao AS, Chung CL, Wu CD, Chang SD, Cheng PJ, Lin YT, Soong YK. Acta Obstet Gynecol Scand; 1999 May; 78(5):393-7. PubMed ID: 10326883 [Abstract] [Full Text] [Related]
18. [Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study]. Qi QW, Jiang YL, Liu JT, Bian XM, Li Y, Lü SM, Zhu BS, Wang H, Xu ZF, Pan XY, Cai Y. Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):737-41. PubMed ID: 19087538 [Abstract] [Full Text] [Related]
19. Detection of fetal Turner syndrome with multiple-marker screening. Wenstrom KD, Williamson RA, Grant SS. Am J Obstet Gynecol; 1994 Feb; 170(2):570-3. PubMed ID: 7509569 [Abstract] [Full Text] [Related]